Question 1

Who are the top researchers at Actelion (Germany)?

Accepted Answer

Ranked on the quality score, Eugen von Philippovich lead among researchers whose main affiliation is Actelion (Germany).

Question 2

What are the most cited papers from Actelion (Germany)?

Accepted Answer

The most cited paper from Actelion (Germany) is "The Endothelin Receptor Antagonist Macitentan Improves Isosorbide‐5‐Mononitrate (ISMN) and Isosorbide Dinitrate (ISDN) Induced Endothelial Dysfunction, Oxidative Stress, and Vascular Inflammation" (Sebastian Steven, Matthias Walter Oelze, Michael Hausding et al., 2018), with 21 citations. Next come "Pharmacological manipulation of L-carnitine transport into L6 cells with stable overexpression of human OCTN2" (20) and "Routine Rehabilitation as a Treatment Component for Patients With Pulmonary Arterial or Chronic Thromboembolic Pulmonary Hypertensions" (3).

Question 3

Which research topics does Actelion (Germany) publish most on?

Accepted Answer

By volume in 2022-now: Sleep and related disorders, Pulmonary Hypertension Research and Treatments, Cardiovascular and exercise physiology and Chronic Obstructive Pulmonary Disease (COPD) Research.

Question 4

Which fields of science does Actelion (Germany) work in?

Accepted Answer

In all years, 67% of research at Actelion (Germany) is in Health Sciences, 29% in Life Sciences. Its largest fields are Medicine (67%), Biochemistry, Genetics and Molecular Biology (29%), Psychology (5%). It does 1.3× the world's share of Health Sciences.

Question 5

Is Actelion (Germany)'s research output growing?

Accepted Answer

Output in 2022-2025 was 8% lower than in 2018-2021.